HEADER MEMBRANE PROTEIN/HYDROLASE 07-MAY-03 1P8V TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND TITLE 2 ALPHA-THROMBIN AT 2.6A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLATELET GLYCOPROTEIN IB ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GLYCOPROTEIN 1B ALPHA; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PROTHROMBIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: ALPHA THROMBIN, LIGHT CHAIN; COMPND 11 SYNONYM: COAGULATION FACTOR II; COMPND 12 EC: 3.4.21.5; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: PROTHROMBIN; COMPND 15 CHAIN: C; COMPND 16 FRAGMENT: ALPHA THROMBIN, HEAVY CHAIN; COMPND 17 SYNONYM: COAGULATION FACTOR II; COMPND 18 EC: 3.4.21.5 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GP1BA; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_ORGAN: OVARY CELLS; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 OTHER_DETAILS: ISOLATED FROM HUMAN PLASMA; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 OTHER_DETAILS: ISOLATED FROM HUMAN PLASMA KEYWDS PLATELET GLYCOPROTEIN RECEPTOR, LEUCINE RICH REPEAT DOMAIN, MEMBRANE KEYWDS 2 PROTEIN-HYDROLASE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.J.DUMAS,R.KUMAR,J.SEEHRA,W.S.SOMERS,L.MOSYAK REVDAT 5 27-OCT-21 1P8V 1 SEQADV HETSYN REVDAT 4 29-JUL-20 1P8V 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 LINK SITE REVDAT 3 13-JUL-11 1P8V 1 VERSN REVDAT 2 24-FEB-09 1P8V 1 VERSN REVDAT 1 22-JUL-03 1P8V 0 JRNL AUTH J.J.DUMAS,R.KUMAR,J.SEEHRA,W.S.SOMERS,L.MOSYAK JRNL TITL CRYSTAL STRUCTURE OF THE GPIBALPHA-THROMBIN COMPLEX JRNL TITL 2 ESSENTIAL FOR PLATELET AGGREGATION JRNL REF SCIENCE V. 301 222 2003 JRNL REFN ISSN 0036-8075 JRNL PMID 12855811 JRNL DOI 10.1126/SCIENCE.1083917 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 27605 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1903 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1903 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE : 0.3070 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 284 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4449 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 217 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.09000 REMARK 3 B22 (A**2) : -0.51000 REMARK 3 B33 (A**2) : 10.59000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.36 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.437 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.351 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.349 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.522 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 37.85 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1P8V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAY-03. REMARK 100 THE DEPOSITION ID IS D_1000019153. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SI(220) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28711 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07100 REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.39200 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG 400, PH 6.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K, PH 6.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.54750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.12550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.88500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.12550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.54750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.88500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE SECOND PART OF THE BIOLOGICAL ASSEMBLY IS GENERATED BY REMARK 300 THE CRYSTALLOGRAPHIC SYMMETRY OPERATION: -X, Y+0.5, -Z+0.5 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 47.09500 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 55.88500 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 88.12550 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR C 147 REMARK 465 TRP C 148 REMARK 465 THR C 149 REMARK 465 ALA C 150 REMARK 465 ASN C 151 REMARK 465 VAL C 152 REMARK 465 GLY C 153 REMARK 465 LYS C 154 REMARK 465 GLU C 259 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 272 CG OD1 OD2 REMARK 470 LYS C 145 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 10 -131.58 68.01 REMARK 500 LYS A 19 76.07 31.86 REMARK 500 LEU A 42 62.09 -107.39 REMARK 500 LEU A 43 75.62 -102.09 REMARK 500 TYR A 54 75.86 -107.57 REMARK 500 ASN A 110 -144.97 -126.83 REMARK 500 LEU A 123 49.30 -92.33 REMARK 500 ASN A 134 -163.44 -109.96 REMARK 500 ASN A 158 -152.70 -119.20 REMARK 500 ASN A 182 -156.51 -114.42 REMARK 500 PRO A 206 49.83 -77.99 REMARK 500 ASN A 242 94.97 -171.07 REMARK 500 ASP A 249 16.63 56.81 REMARK 500 ASP A 252 4.05 -59.75 REMARK 500 PRO A 265 -151.04 -53.50 REMARK 500 ASP A 269 145.89 137.88 REMARK 500 TYS A 276 -166.00 -105.63 REMARK 500 CYS B 4 154.53 -47.10 REMARK 500 PHE B 10 -89.26 -132.07 REMARK 500 LYS B 12 2.75 -60.66 REMARK 500 LYS B 13 28.13 -145.87 REMARK 500 SER C 12 59.80 -146.67 REMARK 500 TYR C 47 82.91 -163.50 REMARK 500 ASN C 53 79.18 -160.19 REMARK 500 HIS C 66 -58.51 -131.59 REMARK 500 GLU C 72 79.46 -66.68 REMARK 500 ILE C 75 -56.70 -121.76 REMARK 500 GLU C 94 -55.21 -121.26 REMARK 500 ASN C 95 22.64 -147.33 REMARK 500 SER C 112 -153.51 -148.31 REMARK 500 GLU C 202 113.01 -31.59 REMARK 500 SER C 226 -65.89 -106.74 REMARK 500 HIS C 242 98.71 -69.94 REMARK 500 REMARK 500 REMARK: NULL DBREF 1P8V A 1 278 UNP P07359 GP1BA_HUMAN 17 294 DBREF 1P8V B 1 29 UNP P00734 THRB_HUMAN 333 361 DBREF 1P8V C 1 258 UNP P00734 THRB_HUMAN 364 621 SEQADV 1P8V ASP A 21 UNP P07359 ASN 37 ENGINEERED MUTATION SEQADV 1P8V TYS A 276 UNP P07359 TYR 292 MODIFIED RESIDUE SEQADV 1P8V TYS A 279 UNP P07359 CLONING ARTIFACT SEQADV 1P8V GLU C 259 UNP P00734 CLONING ARTIFACT SEQRES 1 A 279 HIS PRO ILE CYS GLU VAL SER LYS VAL ALA SER HIS LEU SEQRES 2 A 279 GLU VAL ASN CYS ASP LYS ARG ASP LEU THR ALA LEU PRO SEQRES 3 A 279 PRO ASP LEU PRO LYS ASP THR THR ILE LEU HIS LEU SER SEQRES 4 A 279 GLU ASN LEU LEU TYR THR PHE SER LEU ALA THR LEU MET SEQRES 5 A 279 PRO TYR THR ARG LEU THR GLN LEU ASN LEU ASP ARG CYS SEQRES 6 A 279 GLU LEU THR LYS LEU GLN VAL ASP GLY THR LEU PRO VAL SEQRES 7 A 279 LEU GLY THR LEU ASP LEU SER HIS ASN GLN LEU GLN SER SEQRES 8 A 279 LEU PRO LEU LEU GLY GLN THR LEU PRO ALA LEU THR VAL SEQRES 9 A 279 LEU ASP VAL SER PHE ASN ARG LEU THR SER LEU PRO LEU SEQRES 10 A 279 GLY ALA LEU ARG GLY LEU GLY GLU LEU GLN GLU LEU TYR SEQRES 11 A 279 LEU LYS GLY ASN GLU LEU LYS THR LEU PRO PRO GLY LEU SEQRES 12 A 279 LEU THR PRO THR PRO LYS LEU GLU LYS LEU SER LEU ALA SEQRES 13 A 279 ASN ASN ASN LEU THR GLU LEU PRO ALA GLY LEU LEU ASN SEQRES 14 A 279 GLY LEU GLU ASN LEU ASP THR LEU LEU LEU GLN GLU ASN SEQRES 15 A 279 SER LEU TYR THR ILE PRO LYS GLY PHE PHE GLY SER HIS SEQRES 16 A 279 LEU LEU PRO PHE ALA PHE LEU HIS GLY ASN PRO TRP LEU SEQRES 17 A 279 CYS ASN CYS GLU ILE LEU TYR PHE ARG ARG TRP LEU GLN SEQRES 18 A 279 ASP ASN ALA GLU ASN VAL TYR VAL TRP LYS GLN GLY VAL SEQRES 19 A 279 ASP VAL LYS ALA MET THR SER ASN VAL ALA SER VAL GLN SEQRES 20 A 279 CYS ASP ASN SER ASP LYS PHE PRO VAL TYR LYS TYR PRO SEQRES 21 A 279 GLY LYS GLY CYS PRO THR LEU GLY ASP GLU GLY ASP THR SEQRES 22 A 279 ASP LEU TYS ASP TYR TYS SEQRES 1 B 29 GLU ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SEQRES 2 B 29 SER LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER SEQRES 3 B 29 TYR ILE ASP SEQRES 1 C 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 C 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 C 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 C 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 C 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 C 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 C 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 C 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 C 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 C 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 C 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 C 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 C 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 C 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 C 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 C 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 C 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 C 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 C 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 C 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU MODRES 1P8V ASN C 53 ASN GLYCOSYLATION SITE MODRES 1P8V TYS A 276 TYR O-SULFO-L-TYROSINE MODRES 1P8V TYS A 279 TYR O-SULFO-L-TYROSINE HET TYS A 276 16 HET TYS A 279 17 HET MES A 400 12 HET NAG C 300 14 HET DFP C 500 10 HETNAM TYS O-SULFO-L-TYROSINE HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM DFP DIISOPROPYL PHOSPHONATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 1 TYS 2(C9 H11 N O6 S) FORMUL 4 MES C6 H13 N O4 S FORMUL 5 NAG C8 H15 N O6 FORMUL 6 DFP C6 H15 O3 P FORMUL 7 HOH *217(H2 O) HELIX 1 1 ALA A 49 MET A 52 5 4 HELIX 2 2 ASN A 210 GLU A 212 5 3 HELIX 3 3 ILE A 213 ASN A 223 1 11 HELIX 4 4 ALA A 224 VAL A 227 5 4 HELIX 5 5 ASP A 235 MET A 239 5 5 HELIX 6 6 ASN A 242 VAL A 246 5 5 HELIX 7 7 GLN A 247 SER A 251 5 5 HELIX 8 8 PRO A 255 TYR A 259 5 5 HELIX 9 9 PHE B 10 SER B 14 5 5 HELIX 10 10 THR B 19 GLU B 25 1 7 HELIX 11 11 SER B 26 ILE B 28 5 3 HELIX 12 12 ALA C 41 CYS C 44 5 4 HELIX 13 13 PRO C 48 ASP C 51 5 4 HELIX 14 14 THR C 55 ASN C 57 5 3 HELIX 15 15 ASP C 122 LEU C 130 1 9 HELIX 16 16 GLU C 169 ASP C 175 1 7 HELIX 17 17 LYS C 191 GLY C 195 5 5 HELIX 18 18 LEU C 246 GLY C 258 1 13 SHEET 1 A10 GLU A 5 VAL A 9 0 SHEET 2 A10 HIS A 12 ASN A 16 -1 O ASN A 16 N GLU A 5 SHEET 3 A10 ILE A 35 HIS A 37 1 O ILE A 35 N VAL A 15 SHEET 4 A10 GLN A 59 ASN A 61 1 O GLN A 59 N LEU A 36 SHEET 5 A10 THR A 81 ASP A 83 1 O THR A 81 N LEU A 60 SHEET 6 A10 VAL A 104 ASP A 106 1 O ASP A 106 N LEU A 82 SHEET 7 A10 GLU A 128 TYR A 130 1 O GLU A 128 N LEU A 105 SHEET 8 A10 LYS A 152 SER A 154 1 O SER A 154 N LEU A 129 SHEET 9 A10 THR A 176 LEU A 178 1 O LEU A 178 N LEU A 153 SHEET 10 A10 PHE A 199 PHE A 201 1 O PHE A 199 N LEU A 177 SHEET 1 B 2 THR A 45 SER A 47 0 SHEET 2 B 2 LYS A 69 GLN A 71 1 O GLN A 71 N PHE A 46 SHEET 1 C 8 SER C 5 ASP C 6 0 SHEET 2 C 8 GLN C 161 VAL C 168 -1 O VAL C 162 N SER C 5 SHEET 3 C 8 MET C 185 ALA C 188 -1 O CYS C 187 N VAL C 168 SHEET 4 C 8 GLY C 238 HIS C 242 -1 O TYR C 240 N PHE C 186 SHEET 5 C 8 TRP C 219 TRP C 227 -1 N TRP C 227 O PHE C 239 SHEET 6 C 8 PRO C 208 LYS C 212 -1 N MET C 211 O TYR C 220 SHEET 7 C 8 LYS C 135 GLY C 140 -1 N ARG C 137 O VAL C 210 SHEET 8 C 8 GLN C 161 VAL C 168 -1 O VAL C 163 N VAL C 138 SHEET 1 D 7 LYS C 77 SER C 79 0 SHEET 2 D 7 LEU C 59 ILE C 63 -1 N ILE C 63 O LYS C 77 SHEET 3 D 7 GLN C 15 ARG C 20 -1 N PHE C 19 O LEU C 60 SHEET 4 D 7 GLU C 25 LEU C 32 -1 O GLU C 25 N ARG C 20 SHEET 5 D 7 TRP C 37 THR C 40 -1 O LEU C 39 N SER C 31 SHEET 6 D 7 ALA C 101 LEU C 105 -1 O MET C 103 N VAL C 38 SHEET 7 D 7 LEU C 81 ILE C 86 -1 N TYR C 85 O LEU C 102 SHEET 1 E 2 LEU C 46 TYR C 47 0 SHEET 2 E 2 LYS C 52 ASN C 53 -1 O LYS C 52 N TYR C 47 SSBOND 1 CYS A 4 CYS A 17 1555 1555 2.03 SSBOND 2 CYS A 209 CYS A 248 1555 1555 2.04 SSBOND 3 CYS A 211 CYS A 264 1555 1555 2.04 SSBOND 4 CYS B 4 CYS C 119 1555 1555 2.01 SSBOND 5 CYS C 28 CYS C 44 1555 1555 2.03 SSBOND 6 CYS C 173 CYS C 187 1555 1555 2.04 SSBOND 7 CYS C 201 CYS C 231 1555 1555 2.04 LINK C LEU A 275 N TYS A 276 1555 1555 1.33 LINK C TYS A 276 N ASP A 277 1555 1555 1.33 LINK C TYR A 278 N TYS A 279 1555 1555 1.33 LINK ND2 ASN C 53 C1 NAG C 300 1555 1555 1.71 LINK OG SER C 205 P DFP C 500 1555 1555 1.49 LINK OG SER C 205 O3P DFP C 500 1555 1555 2.05 CISPEP 1 SER C 22 PRO C 23 0 0.94 CRYST1 47.095 111.770 176.251 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021234 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008947 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005674 0.00000